Jee Won Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jee Won Yang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail G. Shapiro
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA
3 shared publications - Zhiyang Jin
California Institute of Technology
3 shared publications - Ting-Yu Wang
California Institute of Technology
2 shared publications Aaron Lopes
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication- Abigail K. R. Lytton-Jean
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
1 shared publication - Ali Khademhosseini
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25827-25840
Ultrasonic Reporter of Kinase Activity
Protein kinases are an essential class of enzymes that regulate cellular signaling pathways, with their dysregulation implicated in pathologies such as cancer and neurodegenerative diseases. Despite the existence of high-performance fluorescent biosensors of kinase activity, it remains challenging to study the function and regulatory pathways of kinases in opaque tissues due to the limited tissue penetration of light. To address this limitation, we report an ultrasonic reporter of kinase activity (UReKA) designed to detect protein kinase A (PKA) activity by altering the ultrasound scattering of gas vesicles (GVs), a unique class of air-filled protein nanostructures. We engineer a GV shell protein to respond to PKA, demonstrate the functionality of UReKA both in purified protein format and expressed in mammalian cells, and showcase its capacity to monitor PKA signaling in response to pharmacological stimulation or genetic mutations. This approach provides a means to visualize cellular functional activity in opaque media, with broad potential for future applications in cancer biology, cellular development, and drug discovery.
- 9 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25827-25840
Open AccessUltrasonic Reporter of Kinase Activity
Protein kinases are an essential class of enzymes that regulate cellular signaling pathways, with their dysregulation implicated in pathologies such as cancer and neurodegenerative diseases. Despite the existence of high-performance fluorescent biosensors of kinase activity, it remains challenging to study the function and regulatory pathways of kinases in opaque tissues due to the limited tissue penetration of light. To address this limitation, we report an ultrasonic reporter of kinase activity (UReKA) designed to detect protein kinase A (PKA) activity by altering the ultrasound scattering of gas vesicles (GVs), a unique class of air-filled protein nanostructures. We engineer a GV shell protein to respond to PKA, demonstrate the functionality of UReKA both in purified protein format and expressed in mammalian cells, and showcase its capacity to monitor PKA signaling in response to pharmacological stimulation or genetic mutations. This approach provides a means to visualize cellular functional activity in opaque media, with broad potential for future applications in cancer biology, cellular development, and drug discovery.
- Open Access
Ultrasonic Reporter of Kinase Activity
Protein kinases are an essential class of enzymes that regulate cellular signaling pathways, with their dysregulation implicated in pathologies such as cancer and neurodegenerative diseases. Despite the existence of high-performance fluorescent biosensors of kinase activity, it remains challenging to study the function and regulation pathways of kinases in opaque tissues due to the limited tissue penetration of light. To address this limitation, we introduce the first ultrasonic reporter of kinase activity (UReKA), designed to detect protein kinase A (PKA) activity by altering the ultrasound scattering of gas vesicles, a unique class of air-filled protein nanostructures. We engineer a gas vesicle shell protein to respond to PKA, demonstrate the functionality of UReKA both in purified protein format and expressed in mammalian cells, and showcase its capacity to monitor PKA signaling in response to pharmacological stimulation or genetic mutation. This work makes it possible to visualize cellular functional activity in opaque media, with broad potential for future applications in cancer biology, cellular development, and drug discovery.
Open AccessUltrasonic Reporter of Kinase Activity
Protein kinases are an essential class of enzymes that regulate cellular signaling pathways, with their dysregulation implicated in pathologies such as cancer and neurodegenerative diseases. Despite the existence of high-performance fluorescent biosensors of kinase activity, it remains challenging to study the function and regulation pathways of kinases in opaque tissues due to the limited tissue penetration of light. To address this limitation, we introduce the first ultrasonic reporter of kinase activity (UReKA), designed to detect protein kinase A (PKA) activity by altering the ultrasound scattering of gas vesicles, a unique class of air-filled protein nanostructures. We engineer a gas vesicle shell protein to respond to PKA, demonstrate the functionality of UReKA both in purified protein format and expressed in mammalian cells, and showcase its capacity to monitor PKA signaling in response to pharmacological stimulation or genetic mutation. This work makes it possible to visualize cellular functional activity in opaque media, with broad potential for future applications in cancer biology, cellular development, and drug discovery.
- Top Cited Papers
- 8 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6747) , 616-623
Imaging-guided deep tissue in vivo sound printing
Three-dimensional printing offers promise for patient-specific implants and therapies but is often limited by the need for invasive surgical procedures. To address this, we developed an imaging-guided deep tissue in vivo sound printing (DISP) platform. By incorporating cross-linking agent–loaded low-temperature–sensitive liposomes into bioinks, DISP enables precise, rapid, on-demand cross-linking of diverse functional biomaterials using focused ultrasound. Gas vesicle–based ultrasound imaging provides real-time monitoring and allows for customized pattern creation in live animals. We validated DISP by successfully printing near diseased areas in the mouse bladder and deep within rabbit leg muscles in vivo, demonstrating its potential for localized drug delivery and tissue replacement. DISP’s ability to print conductive, drug-loaded, cell-laden, and bioadhesive biomaterials demonstrates its versatility for diverse biomedical applications.
- 8 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6747) , 616-623
Top Cited PapersImaging-guided deep tissue in vivo sound printing
Three-dimensional printing offers promise for patient-specific implants and therapies but is often limited by the need for invasive surgical procedures. To address this, we developed an imaging-guided deep tissue in vivo sound printing (DISP) platform. By incorporating cross-linking agent–loaded low-temperature–sensitive liposomes into bioinks, DISP enables precise, rapid, on-demand cross-linking of diverse functional biomaterials using focused ultrasound. Gas vesicle–based ultrasound imaging provides real-time monitoring and allows for customized pattern creation in live animals. We validated DISP by successfully printing near diseased areas in the mouse bladder and deep within rabbit leg muscles in vivo, demonstrating its potential for localized drug delivery and tissue replacement. DISP’s ability to print conductive, drug-loaded, cell-laden, and bioadhesive biomaterials demonstrates its versatility for diverse biomedical applications.
- 25 March 2021
- Published by Springer Nature in Nature Nanotechnology
- Vol. 16 (6) , 725-733
Computationally guided high-throughput design of self-assembling drug nanoparticles
Nanoformulations of therapeutic drugs are transforming our ability to effectively deliver and treat a myriad of conditions. Often, however, they are complex to produce and exhibit low drug loading, except for nanoparticles formed via co-assembly of drugs and small molecular dyes, which display drug-loading capacities of up to 95%. There is currently no understanding of which of the millions of small-molecule combinations can result in the formation of these nanoparticles. Here we report the integration of machine learning with high-throughput experimentation to enable the rapid and large-scale identification of such nanoformulations. We identified 100 self-assembling drug nanoparticles from 2.1 million pairings, each including one of 788 candidate drugs and one of 2,686 approved excipients. We further characterized two nanoparticles, sorafenib–glycyrrhizin and terbinafine–taurocholic acid both ex vivo and in vivo. We anticipate that our platform can accelerate the development of safer and more efficacious nanoformulations with high drug-loading capacities for a wide range of therapeutics.
- 25 March 2021
- Published by Springer Nature in Nature Nanotechnology
- Vol. 16 (6) , 725-733
Computationally guided high-throughput design of self-assembling drug nanoparticles
Nanoformulations of therapeutic drugs are transforming our ability to effectively deliver and treat a myriad of conditions. Often, however, they are complex to produce and exhibit low drug loading, except for nanoparticles formed via co-assembly of drugs and small molecular dyes, which display drug-loading capacities of up to 95%. There is currently no understanding of which of the millions of small-molecule combinations can result in the formation of these nanoparticles. Here we report the integration of machine learning with high-throughput experimentation to enable the rapid and large-scale identification of such nanoformulations. We identified 100 self-assembling drug nanoparticles from 2.1 million pairings, each including one of 788 candidate drugs and one of 2,686 approved excipients. We further characterized two nanoparticles, sorafenib–glycyrrhizin and terbinafine–taurocholic acid both ex vivo and in vivo. We anticipate that our platform can accelerate the development of safer and more efficacious nanoformulations with high drug-loading capacities for a wide range of therapeutics.